- Home
- TC vs CVKD Comparison
TC vs CVKD Comparison
Compare TC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- CVKD
- Stock Information
- Founded
- TC 2010
- CVKD 2022
- Country
- TC China
- CVKD United States
- Employees
- TC N/A
- CVKD N/A
- Industry
- TC Business Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- TC Consumer Discretionary
- CVKD Health Care
- Exchange
- TC Nasdaq
- CVKD Nasdaq
- Market Cap
- TC 26.0M
- CVKD 29.5M
- IPO Year
- TC 2018
- CVKD 2023
- Fundamental
- Price
- TC $0.74
- CVKD $11.49
- Analyst Decision
- TC
- CVKD Strong Buy
- Analyst Count
- TC 0
- CVKD 1
- Target Price
- TC N/A
- CVKD $32.00
- AVG Volume (30 Days)
- TC 42.4K
- CVKD 37.7K
- Earning Date
- TC 08-29-2025
- CVKD 08-06-2025
- Dividend Yield
- TC N/A
- CVKD N/A
- EPS Growth
- TC N/A
- CVKD N/A
- EPS
- TC N/A
- CVKD N/A
- Revenue
- TC $6,737,269.00
- CVKD N/A
- Revenue This Year
- TC N/A
- CVKD N/A
- Revenue Next Year
- TC N/A
- CVKD N/A
- P/E Ratio
- TC N/A
- CVKD N/A
- Revenue Growth
- TC N/A
- CVKD N/A
- 52 Week Low
- TC $0.46
- CVKD $5.70
- 52 Week High
- TC $4.30
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- TC 41.64
- CVKD 43.82
- Support Level
- TC $0.76
- CVKD $10.45
- Resistance Level
- TC $0.79
- CVKD $11.98
- Average True Range (ATR)
- TC 0.03
- CVKD 0.82
- MACD
- TC -0.01
- CVKD 0.01
- Stochastic Oscillator
- TC 0.00
- CVKD 32.64
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.